ProPharma Group has appointed a new chief executive officer and president in the form of Dawn Sherman.
Sherman brings extensive international strategy and experience to the group following multiple executive leadership positions.
Most recently, Sherman was president of EnvisionRxOptions, a role where she was responsible for the pharmacy benefit management and technology company lines of business.
She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market intelligence.
Sherman said: “It is an honour to join ProPharma Group and the great people that have contributed to the company’s success.
“I am incredibly excited about the many opportunities that lie ahead for this dynamic, growing business.
Sherman succeeds Jeff Hargroves, founder and CEO of ProPharma group, who will continue to be an active member of the board.